Non-synergy of PD-1 blockade with T-cell therapy in solid tumors.
Saved in:
| Title: | Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. |
|---|---|
| Authors: | Davies JS; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Safety Assessment, Genentech Inc, South San Francisco, California, USA., Karimipour F; NCI, National Institutes of Health, Bethesda, Maryland, USA., Zhang L; NCI, National Institutes of Health, Bethesda, Maryland, USA., Nagarsheth N; NCI, National Institutes of Health, Bethesda, Maryland, USA., Norberg S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Serna C; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Immuno-Oncology Translational Medicine, AstraZeneca Gaithersburg, Gaithersburg, Maryland, USA., Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Chiou S; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Gulley JL; NCI, National Institutes of Health, Bethesda, Maryland, USA., Hinrichs CS; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA ch977@cinj.rutgers.edu. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35793866 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Davies+JS%22">Davies JS</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Safety Assessment, Genentech Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Karimipour+F%22">Karimipour F</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Nagarsheth+N%22">Nagarsheth N</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Norberg+S%22">Norberg S</searchLink>; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Serna+C%22">Serna C</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.; Immuno-Oncology Translational Medicine, AstraZeneca Gaithersburg, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Strauss+J%22">Strauss J</searchLink>; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chiou+S%22">Chiou S</searchLink>; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Gulley+JL%22">Gulley JL</searchLink>; NCI, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Hinrichs+CS%22">Hinrichs CS</searchLink>; Cancer Immunotherapy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA ch977@cinj.rutgers.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2022 Jul; Vol. 10 (7). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35793866 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2022-004906 Languages: – Code: eng Text: English Titles: – TitleFull: Non-synergy of PD-1 blockade with T-cell therapy in solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Davies JS – PersonEntity: Name: NameFull: Karimipour F – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Nagarsheth N – PersonEntity: Name: NameFull: Norberg S – PersonEntity: Name: NameFull: Serna C – PersonEntity: Name: NameFull: Strauss J – PersonEntity: Name: NameFull: Chiou S – PersonEntity: Name: NameFull: Gulley JL – PersonEntity: Name: NameFull: Hinrichs CS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |
